1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Ludvigsen, S.
Kaarsholm, N.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
279
1
7
10.1006/jmbi.1998.1801
9636695
A structural switch in a mutant insulin exposes key residues for receptor binding.
1998
10.2210/pdb1a7f/pdb
pdb_00001a7f
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2383.698
INSULIN
1
man
polymer
3208.667
INSULIN
Y16E, F24G, DEL(T30)
1
man
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSHLVEALELVCGERGGFYTPK
FVNQHLCGSHLVEALELVCGERGGFYTPK
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
baker's yeast
Saccharomyces
sample
9606
PANCREAS
Homo sapiens
4932
Saccharomyces cerevisiae
human
Homo
baker's yeast
Saccharomyces
sample
9606
PANCREAS
Homo sapiens
4932
Saccharomyces cerevisiae
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1998-07-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
Y
BNL
1998-03-12
REL
REL
LEAST TOTAL ENERGY (TARGET FUNCTION)
50
20
NOESY
DQCOSY
TOCSY
8.0
305
K
DISTANCE GEOMETRY AND SIMULATED ANNEALING
WATER
BRUNGER
refinement
X-PLOR
3.1
structure solution
XwinNMR
structure solution
MNMR
structure solution
Pronto
600
Bruker
AMX600
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
GLU
16
n
16
GLU
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
GLY
24
n
24
GLY
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ILE
2
-123.80
-50.61
1
A
CYS
6
-146.53
43.49
1
A
CYS
11
-84.41
-85.76
1
B
VAL
2
-165.34
-33.42
1
B
ASN
3
-157.88
-42.26
1
B
CYS
19
-94.91
-76.37
1
B
PRO
28
-62.85
86.88
2
A
ILE
2
-137.60
-56.39
2
A
GLU
4
-93.02
42.16
2
A
ILE
10
-110.99
69.81
2
B
GLN
4
-117.66
-84.50
2
B
HIS
5
-178.99
-172.53
2
B
VAL
18
-55.59
-72.11
2
B
CYS
19
-80.68
-74.28
2
B
PRO
28
-58.48
-178.75
3
A
ILE
2
-163.28
-44.40
3
A
CYS
11
-122.58
-160.23
3
A
CYS
20
-95.21
36.15
3
B
ASN
3
-150.35
22.35
3
B
GLN
4
-101.03
-94.54
3
B
HIS
5
178.12
168.27
3
B
TYR
26
-52.47
108.54
4
A
THR
8
-58.66
-82.33
4
A
CYS
11
-62.55
-162.32
4
B
GLN
4
-99.33
43.53
4
B
CYS
7
179.66
142.91
4
B
VAL
18
-85.12
-72.03
4
B
TYR
26
-58.38
109.13
4
B
PRO
28
-52.69
83.96
5
A
ILE
2
-167.53
-55.89
5
A
SER
9
-109.89
-169.38
5
A
CYS
11
-61.95
-174.24
5
B
ASN
3
-156.76
34.20
5
B
CYS
7
179.61
120.61
5
B
ARG
22
-99.86
-64.71
5
B
PHE
25
-176.11
-172.02
5
B
PRO
28
-57.33
109.94
6
A
ILE
2
-141.37
-44.61
6
A
CYS
11
-60.19
-169.44
6
A
ASN
18
-94.49
32.78
6
B
VAL
2
-161.68
-43.81
6
B
ASN
3
-156.98
29.16
6
B
VAL
18
-87.78
-75.19
6
B
CYS
19
-75.74
-76.36
7
A
THR
8
-160.95
-42.92
7
A
SER
9
-154.06
-125.55
7
A
ASN
18
-96.64
37.92
7
B
ASN
3
-142.97
30.09
7
B
CYS
7
179.67
142.58
7
B
CYS
19
-88.68
-70.16
7
B
TYR
26
-49.95
101.66
7
B
PRO
28
-56.81
105.53
8
A
THR
8
-92.64
49.74
8
A
CYS
11
-60.40
-178.83
8
A
ASN
18
-96.27
30.63
8
B
ASN
3
-154.35
24.63
8
B
CYS
19
-58.56
-81.14
8
B
PHE
25
-176.83
-169.44
8
B
TYR
26
-51.52
99.93
9
A
THR
8
-129.73
-66.22
9
A
CYS
11
-70.69
-167.76
9
A
CYS
20
-97.64
33.44
9
B
ASN
3
-144.27
30.04
9
B
GLN
4
-126.65
-159.50
9
B
CYS
19
-79.88
-79.46
9
B
PHE
25
-177.72
-177.32
10
A
ILE
2
-171.99
-50.03
10
A
VAL
3
-92.54
-61.38
10
B
ASN
3
-174.40
36.17
10
B
CYS
7
178.95
-76.71
10
B
TYR
26
-54.50
100.00
10
B
PRO
28
-60.49
89.25
11
A
ASN
18
-96.89
31.95
11
B
ASN
3
-151.57
27.14
11
B
GLN
4
-107.24
-97.21
11
B
CYS
19
-53.71
-78.83
11
B
PHE
25
-178.40
-166.71
11
B
TYR
26
-47.29
94.38
12
A
GLU
4
-90.52
53.58
12
A
GLN
5
-142.22
-46.32
12
A
SER
9
-119.62
-167.86
12
A
ASN
18
-97.74
35.88
12
B
VAL
2
-50.49
172.44
12
B
ASN
3
-58.59
92.54
12
B
CYS
7
-178.46
127.36
12
B
CYS
19
-54.33
-73.29
12
B
PHE
25
-179.33
-173.62
12
B
TYR
26
-54.46
108.36
13
A
CYS
20
-109.31
40.79
13
B
ASN
3
0.77
75.82
13
B
CYS
7
179.78
105.89
13
B
TYR
26
-52.97
95.15
14
A
ILE
2
-146.70
-45.27
14
A
CYS
7
-93.29
43.74
14
A
THR
8
-138.92
-45.22
14
A
CYS
11
-62.46
-174.46
14
A
ASN
18
-98.53
33.38
14
A
CYS
20
-96.47
35.51
14
B
ASN
3
-178.84
37.15
14
B
CYS
7
179.71
120.25
14
B
VAL
18
-86.49
-75.12
14
B
PRO
28
-68.35
83.15
15
A
ILE
2
-136.90
-48.26
15
A
GLN
5
-150.50
-45.96
15
A
CYS
11
-82.80
-89.00
15
A
ASN
18
-98.02
35.33
15
A
CYS
20
-97.97
36.43
15
B
VAL
2
-36.07
-72.83
15
B
ASN
3
-178.16
54.98
15
B
CYS
7
-172.05
120.41
15
B
TYR
26
-55.44
93.52
15
B
PRO
28
-57.64
-172.34
16
A
ILE
2
-143.42
-47.40
16
A
GLN
5
-141.20
-50.48
16
A
SER
9
-116.98
-162.52
16
A
ASN
18
-98.51
32.97
16
B
ASN
3
-171.08
40.85
16
B
LEU
6
-114.42
55.35
16
B
VAL
18
-71.00
-71.76
16
B
CYS
19
-68.10
-77.91
17
A
ILE
2
-170.73
-53.35
17
B
ASN
3
-152.89
29.24
17
B
CYS
19
-69.19
-80.24
18
A
ILE
2
-172.89
-44.40
18
A
SER
9
-117.40
-153.56
18
B
ASN
3
-59.44
92.98
18
B
CYS
19
-66.43
-74.89
18
B
TYR
26
-54.33
109.58
19
A
ILE
2
-172.26
-44.74
19
A
GLU
4
-90.35
51.72
19
A
GLN
5
-138.44
-43.79
19
A
THR
8
-99.29
-67.83
19
A
CYS
11
-61.74
-178.91
19
A
ASN
18
-96.95
33.21
19
A
CYS
20
-96.83
40.49
19
B
ASN
3
-160.69
31.62
19
B
VAL
18
-74.12
-71.21
19
B
ARG
22
-91.93
52.70
20
A
CYS
11
-68.27
-172.82
20
A
CYS
20
-99.31
33.12
20
B
VAL
18
-84.77
-73.19
20
B
CYS
19
-64.49
-82.51
20
B
ARG
22
-93.44
50.74
20
B
TYR
26
-57.69
98.85
20
B
PRO
28
-59.24
-171.34
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES
1
N
N
2
N
N
A
ILE
2
A
ILE
2
HELX_P
A
CYS
7
A
CYS
7
1
HE1
6
A
LEU
13
A
LEU
13
HELX_P
A
TYR
19
A
TYR
19
1
HE2
7
B
SER
9
B
SER
9
HELX_P
B
VAL
18
B
VAL
18
1
HE3
10
disulf
2.019
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.022
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.019
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE
HORMONE, HUMAN INSULIN MUTANT, MONOMER, NEUTRAL PH
INS_HUMAN
UNP
1
90
P01308
INS_HUMAN
UNP
2
25
P01308
90
110
1A7F
1
21
P01308
A
1
1
21
25
53
1A7F
1
29
P01308
B
2
1
29
2
TYR
engineered mutation
GLU
16
1A7F
B
P01308
UNP
40
16
2
PHE
engineered mutation
GLY
24
1A7F
B
P01308
UNP
48
24
1
P 1